Madhav Vasanthavada
Fortuna: 2 M $ al 31/05/2026
Fortuna: 2 M $ al 31/05/2026
Madhav Vasanthavada is currently Chief Commercial Officer at Abeona Therapeutics, Inc. since 2023.
Education history includes a doctorate from the University of Rhode Island, an undergraduate degree from Osmania University, and an MBA from Harvard Business School.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 16/06/2026 | 303.229 ( 0,53 % ) | 2 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ABEONA THERAPEUTICS INC. | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
| Empresas privadas | 4 |
|---|---|
Abeona Therapeutics, Inc.
Abeona Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cell and gene therapies for life-threatening rare genetic diseases | Health Technology |
University of Rhode Island
University of Rhode Island Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Osmania University
Osmania University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.